comparison of glp 1 drugs Mapping the effectiveness and risks GLP-1 receptor agonists developed bundle cultivating targeted restoration across the Gut Is Toujeo a GLP-1? The

These include bowel obstruction, chronic gallbladder disease, pancreatic cancer, liver failure, and other life-threatening diagnoses

[DOI] [PMC free article] [PubMed] [Google Scholar] 690.Baggio L.L., Huang Q., Brown T.J., Drucker D.J

Adverse events were mostly mild-to-moderate gastrointestinal symptoms, consistent with other incretin-based therapies

Additional information Publishers Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

GLP-1R Agonist Therapy for Diabetes: Benefits and Potential Risks

larger trials are ongoing investigating retatrutide for people with type 2 diabetes, non-alcoholic fatty liver disease, and obesity